Please login to the form below
World’s Largest Pharmaceutical Summit Brings Latest Innovations To Light In New Award Ceremony
eyeforpharma, London (February 10th, 2014): eyeforpharma Barcelona, the world’s largest commercial pharmaceutical event has just announced the finalists for their first time award ceremony. Astellas Pharma, Bayer, Pfizer and MSD are amongst the shortlisted companies who will join an exclusive celebration to recognise what really matters when it comes to supporting real patient outcomes.
Five value-driven awards focus on
the
fundamental themes shaping today’s world of pharma. Innovative projects will
demonstrate outstanding level of patient value with clear results. The award
ceremony comes at a time when pharma is trying to reach out to customers and
allow them to shape the direction of their business.
The five categories announced focus on fundamental themes in the following areas; Most valuable patient initiative or service. Most valuable HCP or healthcare initiative. Most impactful emerging or global initiative. Customer Innovator Award and Lifetime Value Achievement.
Astellas Pharma UK are shortlisted for the most valuable patient initative with their ‘over active bladder awareness programme’ whilst Sanofi is shortlisted for their most valuable HCP initiative with their seprefilm virtual training tool.
Judges to shortlist the likes Astellas, Eli Lilly and Sanofi include Michael Baes, VP Innovation at Janssen, Simon Davies, CEO at Teen Cancer and Huw Tippett, VP Global Commercial Excellence at Baxter. The judges will determine a fair and supported decision to announce ground breaking news that will highlight the new leaders across the industry shaping competition for 2014 and beyond.
The award ceremony is to be co-located with the famous eyeforpharma Barcelona conference taking place 18-20th March, 2014. Award winners will be announced on Tuesday 18th March in the evening as a part of this first time industry recognition award ceremony.
For more information on the summit, awards, who else will be in attendance, or to find out how this year’s agenda will influence your future business practices visit the official website.
For more information contact:
Lucy Fisher
EyeforPharma
(+44) 207-375-7225
lfisher@eyeforpharma.com
The five categories announced focus on fundamental themes in the following areas; Most valuable patient initiative or service. Most valuable HCP or healthcare initiative. Most impactful emerging or global initiative. Customer Innovator Award and Lifetime Value Achievement.
Astellas Pharma UK are shortlisted for the most valuable patient initative with their ‘over active bladder awareness programme’ whilst Sanofi is shortlisted for their most valuable HCP initiative with their seprefilm virtual training tool.
Judges to shortlist the likes Astellas, Eli Lilly and Sanofi include Michael Baes, VP Innovation at Janssen, Simon Davies, CEO at Teen Cancer and Huw Tippett, VP Global Commercial Excellence at Baxter. The judges will determine a fair and supported decision to announce ground breaking news that will highlight the new leaders across the industry shaping competition for 2014 and beyond.
The award ceremony is to be co-located with the famous eyeforpharma Barcelona conference taking place 18-20th March, 2014. Award winners will be announced on Tuesday 18th March in the evening as a part of this first time industry recognition award ceremony.
For more information on the summit, awards, who else will be in attendance, or to find out how this year’s agenda will influence your future business practices visit the official website.
For more information contact:
Lucy Fisher
EyeforPharma
(+44) 207-375-7225
lfisher@eyeforpharma.com
